Skip to main content


Evaluating robotic surgery techniques to improve patient outcomes and developing interventions to reduce kidney stone formation and recurrence.


 Amy Krambeck Lab

Studying the pathogenesis of stone disease, urolithiasis during pregnancy, and treatment of benign prostatic hyperplasia.

Research Description

Amy Krambeck, MD is the Chief of the Division of Endourology and Stone Disease and has published extensively on the management of stone disease during pregnancy. She has dedicated her efforts to improve treatment options for women.

She is an active participant in several national research studies analyzing optimal surgical equipment, techniques and protocols for the treatment of stone disease, and has contributed to the American Urological Association guidelines on the surgical management of stone disease.

Dr. Krambeck has a special interest in the treatment of enlarged prostates in the setting of myogenic or weakened bladders. Her BPH research focuses on the use of Holmium Laser Enucleation of the Prostate (HoLEP) for the treatment of symptomatic lower urinary tract symptoms. 

She is also conducting research on healthcare quality improvement, reducing the use of narcotics, and improving the efficiency and safety of current endourologic procedures.

In this podcast, Dr. Krambeck discusses holmium laser enucleation of the prostate (HoLEP) for the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia (BPH).

In this Better Edge podcast, Amy E. Krambeck, MD, professor of Urology and chief of the Division of Endourology and Stone Disease at Northwestern Medicine, discusses “minimizing” thus improving urologic care in the post-COVID era. She talks about patient backlog management, the shift towards same-day discharge, improved efficiencies with innovative technology, and more.



For contact information, see Dr. Krambeck's faculty profile.

 Kent Perry Lab

Evaluating outcomes of minimally invasive and robotic surgery as well as the treatment and management of stone disease

Research Description

Dr. Perry’s research focuses on minimally invasive approaches to kidney cancers and other malignancies. His projects assess the treatment of renal and prostate tumors via robotic, laparoscopic and percutaneous approaches in order to reduce bleeding, complications, post-operative pain and recovery time. His previous projects involved the evaluation of fibrin-based surgical hemostatic agents and the use of image-guided percutaneous renal ablation using intraoperative real-time computed tomography.



Find contact information on Dr. Perry's faculty profile.

Follow Urology on